AstraZeneca COVID-19 vaccine not recommended for Canadians over age 65: NACI

Canada’s National Advisory Committee on Immunization (NACI) is not currently recommending the newly approved COVID-19 vaccine from AstraZeneca be used on people aged 65 or older.

Read more: Canada approves AstraZeneca’s COVID-19 vaccine

According to the NACI website, this is “due to limited information on the efficacy of this vaccine in this age group at this time.”

[ Sign up for our Health IQ newsletter for the latest coronavirus updates ]

However, the agency said the vaccine has “demonstrated an average efficacy of approximately 62 per cent in those aged 18-64 years of age.”

The vaccine received approval from Health Canada on Friday.

Click to play video 'Health Canada approves Oxford-AstraZeneca’s COVID-19 vaccine' 3:06Health Canada approves Oxford-AstraZeneca’s COVID-19 vaccine

Health Canada approves Oxford-AstraZeneca’s COVID-19 vaccine

NACI said it should be delivered in two doses four to 12 weeks apart.

Story continues below advertisement

It became the third vaccine to receive regulatory approval in Canada, joining ones from Moderna and Pfizer-BioNTech.

Canada has ordered 24 million doses of the AstraZeneca vaccine.

-More to come..

© 2021 Global News, a division of Corus Entertainment Inc.

Latest articles

Related articles